BRASILIA, (Reuters) - Russia’s Sputnik V COVID-19 vaccine has requested regulatory approval to launch Phase 3 trials in Brazil, Brazilian health regulator Anvisa said late yesterday.
The article Russia’s Sputnik vaccine applies for Phase 3 study in Brazil appeared first on Stabroek News.
